Product Information
SELZENTRY 300 MG TABLET is a brand product labeled by ViiV Healthcare Company, priced at $28.1311 per EA under NDC 49702022418. Its NADAC has been published 651 times since Nov 28, 2013.
FDA first approved this application on Aug 6, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the maraviroc market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
ViiV Healthcare CompanyNDC
49702022418
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
MARAVIROCApproval Type
New Drug (NDA)
FDA Application
NDA022128FDA Approved
8/6/2007
TE Code
AB
On Market Since
5/16/2011
Pharmacological Classes
Price Statistics
The NADAC for SELZENTRY 300 MG TABLET has been published 651 times since Nov 28, 2013, and over the history we have for it it has risen 61.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $28.1311 per EA |
|---|---|
| All-time high | $28.1311 (Aug 19, 2026) |
| All-time low | $17.4061 (Jan 22, 2014) |
| 52-week high | $28.1311 |
| 52-week low | $28.0198 |
| Median price | $24.9780 |
| Average price | $24.2849 |
| Largest weekly change | +7.9% (Jan 10, 2018) |
| Weeks tracked | 651 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the maraviroc market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SELZENTRY 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SELZENTRY 300 MG TABLET, manufactured by ViiV Healthcare Company, is $28.1311 per EA (NDC 49702022418), effective Aug 19, 2026.
How has the price of SELZENTRY 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for SELZENTRY 300 MG TABLET has risen 61.2%. It has been tracked across 651 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SELZENTRY 300 MG TABLET?
Since Nov 28, 2013, the NADAC for SELZENTRY 300 MG TABLET has ranged from a low of $17.4061 (Jan 22, 2014) to a high of $28.1311 (Aug 19, 2026), with a median of $24.9780 per EA.
Are there cheaper alternatives to SELZENTRY 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SELZENTRY 300 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SELZENTRY 300 MG TABLET?
SELZENTRY 300 MG TABLET (NDC 49702022418) is labeled by ViiV Healthcare Company, and CMS classifies it as a brand product.